RxDoctor Payments Data

Amy Metzger, CNM

Advanced Practice Midwife · Westfield, MANPI 1447297197

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $360 of the $425 with a category attached, or 84.7%. It is spread thinly across 9 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $212 and has fallen 57.6% since, to $90 in 2024.

$425in general payments, 2019–2025

Across 18 payments — averaging $23.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$86
  • Organon$71
  • Amgen$59
  • AbbVie$50
  • Exeltis, USA Inc.$46
  • Shield Therapeutics Inc$39
  • plus $74 from 3 others

What the payments were for

  • Food & beverage$36085%
  • Education$6515%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$425 in reported general payments places this provider in the 85th percentile of 159 advanced practice midwife providers in Massachusetts.

See all advanced practice midwife providers in Massachusetts

Medicare billing

Part B allowed, 2024
$3,305
Medicare patients
38
Services billed
55

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
YuvafemEstradiol12$2,511
Estradiol13$1,496
Alendronate Sodium33$374
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$268

Paid to pharmacies, not to this prescriber.

Other advanced practice midwife in Westfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →